Disease ยท HP_0002315
Headache
6 sourcesdiseases-2026-09-18-0.1.0
Cite this record
ConductScience Library. Headache. Diseases, record HP_0002315. Release diseases-2026-09-18-0.1.0, 18 Sept 2026. https://conductscience.org/library/diseases/HP_0002315
On this page
Disease
Names and IDs as Open Targets gives them. Its IDs in MeSH, Orphanet, the Disease Ontology and the NCI Thesaurus are those Open Targets states for it.
- Name
- Headache
- Open Targets ID
- HP_0002315
- Other names
- Headaches
- Highest stage of its drugs
- Approval, for 25 of its 82 drugs, from DailyMed and TTD
Source Open Targets
Drugs82
The drugs Open Targets' clinical reports study for the disease, the highest stage first, then the most trial reports. The stage is Open Targets', the highest any of its sources reports for the pair, and each row names the sources that report it.
| Drug | ChEMBL ID | Type | Open Targets' stage | Stage reported by | Reports | Of them trials | Trials shown here | Source |
|---|---|---|---|---|---|---|---|---|
| ACETAMINOPHEN | CHEMBL112 | Small molecule | Approval | DailyMed | 113 | 5 | 5 | Drugs and targets |
| IBUPROFEN | CHEMBL521 | Small molecule | Approval | DailyMed | 15 | 5 | 5 | Drugs and targets |
| CAFFEINE | CHEMBL113 | Small molecule | Approval | DailyMed | 5 | 2 | 2 | Drugs and targets |
| ASPIRIN | CHEMBL25 | Small molecule | Approval | DailyMed | 17 | 1 | 1 | Drugs and targets |
| DEXTROMETHORPHAN HYDROBROMIDE | CHEMBL1256818 | Small molecule | Approval | DailyMed | 70 | 0 | 0 | Drugs and targets |
| PHENYLEPHRINE HYDROCHLORIDE | CHEMBL1200339 | Small molecule | Approval | DailyMed | 60 | 0 | 0 | Drugs and targets |
| GUAIFENESIN | CHEMBL980 | Small molecule | Approval | DailyMed | 35 | 0 | 0 | Drugs and targets |
| DIPHENHYDRAMINE HYDROCHLORIDE | CHEMBL1620 | Small molecule | Approval | DailyMed | 19 | 0 | 0 | Drugs and targets |
| CHLORPHENIRAMINE MALEATE | CHEMBL1659 | Small molecule | Approval | DailyMed | 11 | 0 | 0 | Drugs and targets |
| TRIPROLIDINE HYDROCHLORIDE | CHEMBL3188034 | Small molecule | Approval | DailyMed | 6 | 0 | 0 | Drugs and targets |
1 to 10 of 82
See all 82 drugsTargets114
The targets ChEMBL's mechanism records give for the disease's drugs, through Open Targets, the most drugs first. A mechanism record says what a drug acts on, not that the target causes the disease.
| Target | Protein | Its drugs that act on it | Mechanisms | Highest stage of those drugs | Gene in Genes | Source |
|---|---|---|---|---|---|---|
| PTGS2 | Cyclooxygenase | 10 | Cyclooxygenase inhibitor; Cyclooxygenase-2 inhibitor | Approval | https://conductscience.org/library/genes/5743 | Drugs and targets |
| PTGS1 | Cyclooxygenase | 9 | Cyclooxygenase inhibitor | Approval | https://conductscience.org/library/genes/5742 | Drugs and targets |
| HRH1 | Histamine H1 receptor | 7 | Histamine H1 receptor antagonist | Approval | https://conductscience.org/library/genes/3269 | Drugs and targets |
| ADRA1A | Adrenergic receptor alpha | 5 | Adrenergic receptor alpha agonist; Adrenergic receptor alpha-1 agonist; Adrenergic receptor alpha-1 antagonist | Approval | https://conductscience.org/library/genes/148 | Drugs and targets |
| ADRA1B | Adrenergic receptor alpha | 5 | Adrenergic receptor alpha agonist; Adrenergic receptor alpha-1 agonist; Adrenergic receptor alpha-1 antagonist | Approval | https://conductscience.org/library/genes/147 | Drugs and targets |
| ADRA1D | Adrenergic receptor alpha | 5 | Adrenergic receptor alpha agonist; Adrenergic receptor alpha-1 agonist; Adrenergic receptor alpha-1 antagonist | Approval | https://conductscience.org/library/genes/146 | Drugs and targets |
| SCN4A | Sodium channel alpha subunit | 4 | Sodium channel alpha subunit blocker; Sodium channel protein type IV alpha subunit blocker | Phase 3 | https://conductscience.org/library/genes/6329 | Drugs and targets |
| ADRA2A | Adrenergic receptor alpha | 3 | Adrenergic receptor alpha agonist; Adrenergic receptor alpha-2 agonist | Approval | https://conductscience.org/library/genes/150 | Drugs and targets |
| ADRA2B | Adrenergic receptor alpha | 3 | Adrenergic receptor alpha agonist; Adrenergic receptor alpha-2 agonist | Approval | https://conductscience.org/library/genes/151 | Drugs and targets |
| ADRA2C | Adrenergic receptor alpha | 3 | Adrenergic receptor alpha agonist; Adrenergic receptor alpha-2 agonist | Approval | https://conductscience.org/library/genes/152 | Drugs and targets |
1 to 10 of 114
See all 114 targetsTrials61
Trials an Open Targets clinical report links to the disease, posted results first, then the largest. A trial is shown when the release's checks confirm its link to the disease and Drugs and targets shows its link to one of the disease's drugs. 5 more are not shown, since the checks do not confirm them.
| Trial | Title | Phase | Participants | Results first posted | Conditions | Drugs | Linked by | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00754065 | To Compare SH T00658ID Over Ortho Tri-Cyclen Lo (US/Canada) | Phase 3 | 409 | 2012-08-28 | Contraception | DIENOGEST, ESTRADIOL VALERATE | Its record names the disease | ClinicalTrials.gov |
| NCT03441269 | Adult Oral Ibuprofen Study for ED Pain Patients | Phase 4 | 225 | 2020-06-04 | Pain, Acute | IBUPROFEN | Its record names the disease | ClinicalTrials.gov |
| NCT03220958 | Metoclopramide for Post Traumatic Headache | Phase 3 | 160 | 2021-11-09 | Post-Traumatic Headache | DIPHENHYDRAMINE, METOCLOPRAMIDE | Its record names the disease | ClinicalTrials.gov |
| NCT05967442 | Magnesium Versus Prochlorperazine Versus Metoclopramide for Migraines | Phase 3 | 157 | 2024-10-01 | Migraine, Headache | MAGNESIUM SULFATE, MAGNESIUM SULFATE ANHYDROUS, METOCLOPRAMIDE, PROCHLORPERAZINE | Its record names the disease | ClinicalTrials.gov |
| NCT00680823 | Study of Intramuscular Ropivacaine Injections for Treatment of Pediatric Headache | Not applicable | 150 | 2017-12-13 | Headache, Migraine | ROPIVACAINE | Its record names the disease | ClinicalTrials.gov |
| NCT01048502 | Fenofibrate and Omega-3 Fatty Acid Modulation of Endotoxemia | Not applicable | 100 | 2016-02-19 | Cardiovascular Disease | FENOFIBRATE, OMEGA-3 FATTY ACIDS | Its record names the disease | ClinicalTrials.gov |
| NCT00856232 | Oxygen Therapy for the Treatment of Undifferentiated Headache in the Emergency Department | Not applicable | 91 | 2013-05-03 | Headache | AIR, MEDICAL, OXYGEN | Its record names the disease | ClinicalTrials.gov |
| NCT02266329 | Chronic Postconcussive Headache: A Placebo-Controlled Treatment Trial of Prazosin | Phase 1/2 | 89 | 2024-06-26 | Posttraumatic Headache, Combat Disorders, Post Concussion Syndrome, Headache, Mild Traumatic Brain Injury, Posttraumatic Migraine | PRAZOSIN HYDROCHLORIDE | Its record names the disease | ClinicalTrials.gov |
| NCT02268058 | Use of Ibuprofen and Acetaminophen for Treatment of Acute Headache Post Concussion in Children | Not applicable | 80 | 2016-10-20 | Concussion, Headache | ACETAMINOPHEN, IBUPROFEN | Its record names the disease | ClinicalTrials.gov |
| NCT02295280 | A Cost Effective Treatment for Headache in Pregnancy When Acetaminophen Alone is Ineffective. | Not applicable | 70 | 2018-04-02 | Headache | CODEINE, DIPHENHYDRAMINE, METOCLOPRAMIDE | Its record names the disease | ClinicalTrials.gov |
1 to 10 of 61
See all 61 trialsComparisons in its trials32
Comparisons Trial comparisons calculated in the trials shown here, most participants first. A comparison in one of these trials does not always compare a treatment for the disease, so read the two groups.
| Comparison | Group 1, with the outcome | Group 2, with the outcome | Participants | Trial | Source |
|---|---|---|---|---|---|
| Estradiol Valerate, Dienogest (Natazia, Qlaira, BAY86-5027) vs Ortho Tri-Cyclen Lo: serious adverse events | 2 of 191 | 5 of 204 | 395 | NCT00754065 | Trial comparisons |
| Metoclopramide vs Placebo: deaths from any cause | 0 of 81 | 0 of 79 | 160 | NCT03220958 | Trial comparisons |
| Metoclopramide vs Placebo: serious adverse events | 0 of 81 | 0 of 79 | 160 | NCT03220958 | Trial comparisons |
| Metoclopramide vs Placebo: Sustained Headache Relief | 24 of 78 | 18 of 76 | 154 | NCT03220958 | Trial comparisons |
| Prazosin vs Placebo: deaths from any cause | 0 of 59 | 0 of 30 | 89 | NCT02266329 | Trial comparisons |
| Prazosin vs Placebo: serious adverse events | 1 of 59 | 1 of 30 | 89 | NCT02266329 | Trial comparisons |
| Metoclopramide & Diphenhydramine vs Codeine: deaths from any cause | 0 of 35 | 0 of 35 | 70 | NCT02295280 | Trial comparisons |
| Metoclopramide & Diphenhydramine vs Codeine: serious adverse events | 0 of 35 | 0 of 35 | 70 | NCT02295280 | Trial comparisons |
| Metoclopramide IV & Diphenhydramine IV vs Codeine: Number of Participants With Adequate Relief of Headache as a Measure of Efficacy | 34 of 34 | 32 of 32 | 66 | NCT02295280 | Trial comparisons |
| Treatment vs Standard Care: Incidence of Immediate and Post-discharge Complications. | 2 of 12 | 1 of 11 | 23 | NCT01785459 | Trial comparisons |
1 to 10 of 32
See all 32 comparisons in its trialsPapers from its trials58
The papers the trials shown here list on ClinicalTrials.gov as their results (RESULT) or as drawn from them (DERIVED), results first, newest first.
Data dates
The date of each source this release read.
Sources 6
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- NLM's MeSHNLM's terms
- Open TargetsCC0 1.0
- PubMedNLM's terms
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- NLM's MeSHNLM's
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this disease from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/diseases/v1/HP_0002315
GET https://conductscience.org/api/diseases/v1/HP_0002315/drugs?page=2